Award_Synopsis.pdf

PDF 13 KB Posted

Attached to
Staged Vaccine Development
Solicitation number
BAA-NIAID-DAIDS-NIHAI2014014
Issued by

About this file

From the source

Award Synopsis 2 - University of Massachusetts Medical School

View the file

Other files

File Type Posted
Award_Synopsis.pdf PDF
Amendment_3_NIAID-DAIDS-NIHAI2014014_FINAL.pdf PDF
Amendment_2_NIAID-DAIDS-NIHAI2014014.pdf PDF
Amendment_1_NIAID-DAIDS-NIHAI2014014.pdf PDF
Solicitation_SVD_BAA_No_NAID-DAIDS-NIHAI2014014-Attachments_1-22.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

AWARD SYNOPSIS

Type: Award

Date of Award: May 15, 2016

Period of Performance (including all options): May 15, 2016 through May 14, 2023

Title: "Production of a Quadra-Valent Recombinant gp120 Protein Vaccine Formulation for Clinical Testing”

(RFP) No.: NIAID-DAIDS-NIHAI2014014

NAICS: 541712, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Contract Number: HHSN272201600011C (University of Massachusetts Medical School)

Total Estimated Cost (Including all Options): $17,298,573 (University of Massachusetts Medical School)

Place of Performance/Awardee:

University of Massachusetts Medical School 55 Lake Avenue North Worcester, MA 01655

Primary Point of Contact at NIAID: Kishan Patel Contracting Officer patelki@niaid.nih.gov mailto:patelki@niaid.nih.gov

File details come from the government source that posted it. Updated .